PhaseRx Receives $1,500,016 New Financing

  • Feed Type
  • Date
    12/26/2012
  • Company Name
    PhaseRx
  • Mailing Address
    410 West Harrison Street Seattle, WA 98119
  • Company Description
    The company is developing therapies via sIRNA technologies.
  • Website
    http://www.phaserx.com
  • Transaction Type
    Debt
  • Transaction Amount
    $1,500,016
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.